- Home
- NVAX vs BMEZ Comparison
NVAX vs BMEZ Comparison
Compare NVAX & BMEZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- BMEZ
- Stock Information
- Founded
- NVAX 1987
- BMEZ N/A
- Country
- NVAX United States
- BMEZ United States
- Employees
- NVAX N/A
- BMEZ N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- BMEZ Trusts Except Educational Religious and Charitable
- Sector
- NVAX Health Care
- BMEZ Finance
- Exchange
- NVAX Nasdaq
- BMEZ Nasdaq
- Market Cap
- NVAX 1.3B
- BMEZ 1.5B
- IPO Year
- NVAX 1995
- BMEZ N/A
- Fundamental
- Price
- NVAX $6.00
- BMEZ $13.66
- Analyst Decision
- NVAX Buy
- BMEZ
- Analyst Count
- NVAX 6
- BMEZ 0
- Target Price
- NVAX $17.83
- BMEZ N/A
- AVG Volume (30 Days)
- NVAX 6.0M
- BMEZ 391.3K
- Earning Date
- NVAX 05-09-2025
- BMEZ 01-01-0001
- Dividend Yield
- NVAX N/A
- BMEZ 8.71%
- EPS Growth
- NVAX N/A
- BMEZ N/A
- EPS
- NVAX N/A
- BMEZ 0.54
- Revenue
- NVAX $682,162,000.00
- BMEZ N/A
- Revenue This Year
- NVAX $1.07
- BMEZ N/A
- Revenue Next Year
- NVAX N/A
- BMEZ N/A
- P/E Ratio
- NVAX N/A
- BMEZ $30.17
- Revenue Growth
- NVAX N/A
- BMEZ N/A
- 52 Week Low
- NVAX $3.81
- BMEZ $12.93
- 52 Week High
- NVAX $23.86
- BMEZ $16.95
- Technical
- Relative Strength Index (RSI)
- NVAX 41.41
- BMEZ 37.79
- Support Level
- NVAX $5.01
- BMEZ $12.93
- Resistance Level
- NVAX $6.58
- BMEZ $14.25
- Average True Range (ATR)
- NVAX 0.65
- BMEZ 0.52
- MACD
- NVAX 0.02
- BMEZ 0.01
- Stochastic Oscillator
- NVAX 50.25
- BMEZ 46.35
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About BMEZ BlackRock Health Sciences Term Trust of Beneficial Interest
BlackRock Health Sciences Trust II is a closed-ended management investment company. The investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of energy and natural resources companies and equity derivatives with exposure to the energy and natural resources industry.